<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Validation of Fully-Automated Deep Learning-Based Fibroglandular Tissue Segmentation for Efficient and Reliable Quantitation of Background Parenchymal Enhancement in Breast MRI - Health AI Hub</title>
    <meta name="description" content="This paper validates a fully-automated deep learning (DL)-based method for segmenting fibroglandular tissue (FGT) in breast MRI to quantify background parenchym">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Validation of Fully-Automated Deep Learning-Based Fibroglandular Tissue Segmentation for Efficient and Reliable Quantitation of Background Parenchymal Enhancement in Breast MRI</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.07088v1" target="_blank">2511.07088v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-10
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yu-Tzu Kuo, Anum S. Kazerouni, Vivian Y. Park, Wesley Surento, Suleeporn Sujichantararat, Daniel S. Hippe, Habib Rahbar, Savannah C. Partridge
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> eess.IV, physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.07088v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.07088v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper validates a fully-automated deep learning (DL)-based method for segmenting fibroglandular tissue (FGT) in breast MRI to quantify background parenchymal enhancement (BPE), a potential breast cancer risk marker. The DL method outperformed a semi-automated fuzzy c-means approach by yielding higher quality segmentations and stronger correlations with qualitative BPE assessments, promising more efficient and standardized breast cancer risk evaluation.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate and quantitative assessment of background parenchymal enhancement (BPE) on breast dynamic contrast-enhanced MRI is vital as it serves as a promising biomarker for breast cancer risk. This study's validated automated deep learning method provides a more precise, objective, and efficient tool than current qualitative or semi-automated methods, potentially leading to more standardized and personalized breast cancer risk stratification.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application involves using deep learning for fully-automated segmentation of fibroglandular tissue in breast MRI. This segmentation is crucial for quantifying Background Parenchymal Enhancement (BPE), which serves as a potential breast cancer risk marker. By automating this process, the AI aims to enhance efficiency, provide objective measurements, and improve the standardization of breast cancer risk assessment, moving from qualitative radiologist assessment to quantitative, AI-driven evaluation.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>The study aimed to validate an existing open-source, fully-automated deep learning (DL)-based method for fibroglandular tissue (FGT) segmentation in breast MRI.</li>
                    
                    <li>The primary goal of FGT segmentation was to enable efficient and reliable quantification of background parenchymal enhancement (BPE).</li>
                    
                    <li>The DL-based method was directly compared against a semi-automated fuzzy c-means segmentation method.</li>
                    
                    <li>Evaluation involved breast MRI examinations from 100 women, assessing segmentation agreement, concordance of quantitative BPE metrics, and correlation with qualitative BPE assessments.</li>
                    
                    <li>A radiologist scored the quality of FGT segmentations produced by both methods.</li>
                    
                    <li>Results showed that while both methods had good agreement for quantitative BPE, DL-based measures correlated more strongly with qualitative BPE and its segmentations were deemed higher quality by the radiologist.</li>
                    
                    <li>The findings suggest the DL-based approach enhances efficiency for objective BPE quantification and can improve standardized breast cancer risk assessment.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved evaluating an existing open-source, fully-automated deep learning-based method for fibroglandular tissue (FGT) segmentation in breast MRI. This DL method was compared head-to-head with a semi-automated fuzzy c-means method. The comparison utilized breast MRI data from 100 women, assessing parameters such as segmentation agreement, concordance across quantitative BPE metrics, the strength of association with qualitative BPE assessments, and the overall quality of FGT segmentations as scored by a radiologist.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The deep learning-based FGT segmentation method demonstrated good agreement with the semi-automated fuzzy c-means method for quantitative BPE measurements. Significantly, the DL-based quantitative BPE measures exhibited stronger correlations with qualitative BPE assessments made by radiologists. Furthermore, the FGT segmentations generated by the DL method were consistently scored as higher quality by the radiologist, indicating superior performance in terms of accuracy and clinical relevance.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This fully-automated deep learning method has the potential to profoundly impact clinical practice by providing an efficient, objective, and standardized way to quantify background parenchymal enhancement (BPE). This improvement over qualitative and semi-automated methods can lead to more precise and reliable breast cancer risk assessment, supporting better patient management, personalized screening recommendations, and potentially reducing inter-reader variability in breast MRI interpretation.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the study, such as cohort diversity, external validation, or specific technical constraints of the deep learning model.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention specific future research directions, but it strongly implies that the adoption of such DL-based methods will lead to improved, standardized breast cancer risk assessment in clinical settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Breast Imaging</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                    <span class="tag">Diagnostic Imaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Fibroglandular Tissue</span>
                    
                    <span class="tag tag-keyword">Background Parenchymal Enhancement</span>
                    
                    <span class="tag tag-keyword">Breast MRI</span>
                    
                    <span class="tag tag-keyword">Segmentation</span>
                    
                    <span class="tag tag-keyword">Breast Cancer Risk</span>
                    
                    <span class="tag tag-keyword">Quantitative Biomarkers</span>
                    
                    <span class="tag tag-keyword">Radiology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Background parenchymal enhancement (BPE) on breast dynamic contrast-enhanced
magnetic resonance imaging (DCE-MRI) shows potential as a breast cancer risk
marker. Clinically, BPE is qualitatively assessed by radiologists, but
quantitative BPE measures offer potential for more precise risk evaluation.
This study evaluated an existing open-source, fully-automated deep
learning-based (DL-based) method for segmenting fibroglandular tissue (FGT) to
quantify BPE and compared it to a semi-automated fuzzy c-means method. Using
breast MRI examinations from 100 women, we evaluated segmentation agreement,
concordance across quantitative BPE metrics, and associations with qualitative
BPE. The quality of FGT segmentations from both methods was scored by a
radiologist. While the DL-based and semi-automated methods showed good
agreement for quantitative BPE measurements, DL-based measures more strongly
correlated with qualitative BPE assessments and DL-based segmentations were
scored as higher quality by the radiologist. Our findings suggest that DL-based
FGT segmentation enhances efficiency for objective BPE quantification and may
improve standardized breast cancer risk assessment.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>